C. Tucker Barrie
Director/Board Member at NORAM LITHIUM CORP.
Net worth: 159 526 $ as of 31/05/2024
Network origin in C. Tucker Barrie first degree
| Entity | Entity type | Industry | |
|---|---|---|---|
| Public Company | Precious Metals | 10 | |
| Public Company | Other Metals/Minerals | 7 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to C. Tucker Barrie via their personal network
| Company | Sector | Related people | Main position |
|---|---|---|---|
| NORDION INC | Pharmaceuticals: Major | Corporate Officer/Principal | |
| DELORO RESOURCES LTD | Oil & Gas Production | Director/Board Member | |
| MICROBIX BIOSYSTEMS INC. | Biotechnology | Director/Board Member | |
| AMERICAN LITHIUM CORP. | Chemicals: Agricultural | Chief Executive Officer | |
| CDN MAVERICK CAPITAL CORP. | Precious Metals | Chief Executive Officer Director of Finance/CFO Chief Executive Officer | |
| FOCUS GRAPHITE INC. | Other Metals/Minerals | Director/Board Member Director of Finance/CFO | |
PNO Resources Ltd.
 PNO Resources Ltd. Other Metals/MineralsNon-Energy Minerals PNO Resources Ltd. engages in the acquisition and exploration of natural resource properties. The company was founded on February 22, 1983 and is headquartered in Vancouver, Canada. | Other Metals/Minerals | President | |
| CANADIAN NEXUS TEAM VENTURES CORP. | Investment Managers | Director/Board Member | |
| AVARONE METALS INC. | Precious Metals | Director of Finance/CFO | |
| MAXIM RESOURCES INC. | Oil & Gas Production | Chief Executive Officer Director of Finance/CFO | |
| NORSEMONT MINING INC. | Precious Metals | Chief Executive Officer | |
| GALIANO GOLD INC. | Precious Metals | Director of Finance/CFO | |
| ASIAN DRAGON GROUP INC | Precious Metals | Director/Board Member Director/Board Member | |
Cita NeuroPharmaceuticals, Inc.
 Cita NeuroPharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Cita Neuro Pharmaceuticals, Inc. develops and commercializes small molecule drugs. Its clinical drug portfolio consists of drugs for Parkinson's disease and neuropathic pain. Cita Neuro Pharmaceuticals was founded in 1997 by Brian Bennett, Roland Boegman, Khem Jha-mandas, James Reynolds and Gregory Thatcher and is headquartered in Mississauga, Canada. | Pharmaceuticals: Major | Chief Executive Officer | |
| ALIO GOLD INC. | Precious Metals | Chief Executive Officer | |
| ZINCORE METALS INC. | Precious Metals | Corporate Officer/Principal | |
| KINGMAN MINERALS LTD. | Precious Metals | Chairman Director/Board Member Director/Board Member | |
| TETRA BIO-PHARMA INC. | Pharmaceuticals: Other | Chief Executive Officer Director of Finance/CFO | |
| Simact Mining Holding, Inc. | Corporate Officer/Principal President | ||
| FURY GOLD MINES LIMITED | Precious Metals | Director/Board Member | |
ZyVersa Therapeutics Operating, Inc.
 ZyVersa Therapeutics Operating, Inc. Pharmaceuticals: MajorHealth Technology ZyVersa Therapeutics Operating, Inc. operates as a specialty pharmaceutical company, which develops and commercializes prescription pharmaceutical products. The firm focuses on developing products for the treatment of men?s health, as well as for other markets where current therapies are suboptimal and underdeveloped. It offers VAR 100, an oral formulation of native testosterone to treat male hypogonadism; and VAR 200 that minimizes and prevents kidney cell damage, and improves focal segmental glomerulosclerosis prognosis. The company was founded by Stephen C. Glover and Shawn M. Titcomb in 2014 and is headquartered in Weston, FL. | Pharmaceuticals: Major | Director/Board Member | |
Neurotrophic Bioscience, Inc.
 Neurotrophic Bioscience, Inc. Pharmaceuticals: MajorHealth Technology Neurotrophic Bioscience, Inc. develops pharmaceutical products. | Pharmaceuticals: Major | President | |
| FREE BATTERY METAL LIMITED | Other Metals/Minerals | Director of Finance/CFO | |
| Concordia University | College/University | Undergraduate Degree Undergraduate Degree | |
| University of Ottawa | College/University | Undergraduate Degree Undergraduate Degree | |
| University of Quebec | College/University | Graduate Degree Undergraduate Degree | |
| International Institute for Management Development | College/University | Masters Business Admin | |
Hunter Dickinson, Inc.
 Hunter Dickinson, Inc. Construction MaterialsNon-Energy Minerals Hunter Dickinson, Inc. explores and develops mineral properties. It offers services in the different parts of the Canada. The company was founded by Robert A. Dickinson and Robert Hunter in 1985 and is headquartered in Vancouver, Canada. | Construction Materials | Corporate Officer/Principal | |
PhytoPain Pharma, Inc.
 PhytoPain Pharma, Inc. Pharmaceuticals: OtherHealth Technology PhytoPain Pharma, Inc. engages in the development and commercialization of botanical medicines. The company is headquartered in Canada, Canada. | Pharmaceuticals: Other | Director/Board Member Director/Board Member | |
| GOLD LINE RESOURCES | Specialty Telecommunications | Director/Board Member Director/Board Member | |
Valo Therapeutics Oy
 Valo Therapeutics Oy Pharmaceuticals: MajorHealth Technology Valo Therapeutics Oy is an immunotherapy company based in Helsinki, FI. The Finnish company is focused on developing innovative immunotherapy approaches against cancer and infectious disease. Valo Therapeutics's lead platform, PeptiCRAd, was developed out of the laboratory of Professor Vincenzo Cerullo at the University of Helsinki. The company is also developing PeptiEnv and PeptiVax, among other neoantigen strategies, in collaboration with Professor Cerullo. The company's PeptiChip technology enables the rapid and accurate identification of tumor antigens. Valo Therapeutics is also developing antigen-coated oncolytic viruses as anti-cancer therapeutic vaccines. The company was founded in 2016, and Paul Grant Higham has been the CEO of the company since 2020. | Pharmaceuticals: Major | Director/Board Member | |
Kalgene Pharmaceuticals, Inc.
 Kalgene Pharmaceuticals, Inc. Medical/Nursing ServicesHealth Services Kalgene Pharmaceuticals, Inc. develops and focuses on personalized cancer diagnostics and drugs. It offers drugs for epithelial and thyroid cancers. The firm's oncology programs are aimed at improving clinical and survival outcomes through the use of personalized medicine, with a particular focus on bladder, epithelial and thyroid cancers. It serves the biopharmaceutical, research and development and health industries. The company is headquartered in Kingston, Canada. | Medical/Nursing Services | Chairman | |
| XORTX THERAPEUTICS INC. | Pharmaceuticals: Major | Chairman | |
| TORQ RESOURCES INC. | Other Metals/Minerals | President | |
| POND TECHNOLOGIES HOLDINGS INC. | Pharmaceuticals: Other | Director/Board Member | |
| TITAN MEDICAL INC. | Medical Specialties | Director/Board Member | |
| ELECTRA BATTERY MATERIALS CORPORATION | Electrical Products | Chief Executive Officer | |
Mondor Minerals, Inc.
 Mondor Minerals, Inc. Other Metals/MineralsNon-Energy Minerals Mondor Minerals, Inc. engages in the acquisition and exploration of mineral properties. The company was founded on February 12, 2018 and is headquartered in Vancouver, Canada. | Other Metals/Minerals | Chief Executive Officer |
Statistics
International
| Canada | 43 |
| United States | 5 |
| Switzerland | 2 |
| Finland | 2 |
| Ireland | 2 |
Sectoral
| Non-Energy Minerals | 22 |
| Health Technology | 15 |
| Consumer Services | 5 |
| Energy Minerals | 3 |
| Finance | 3 |
Operational
| Director/Board Member | 121 |
| Director of Finance/CFO | 65 |
| President | 37 |
| Chief Executive Officer | 31 |
| Independent Dir/Board Member | 31 |
Most connected contacts
| Insiders | |
|---|---|
| Cyrus Driver | 31 |
| Sabino di Paola | 24 |
| Alain Krushnisky | 23 |
| Anthony Giovinazzo | 22 |
| Arthur Brown | 21 |
| André Audet | 20 |
| Jacques Trottier | 19 |
| Anita Algie | 16 |
| Daniel F. Hachey | 15 |
| Gregory McCunn | 10 |
| Jean-Marie Wolff | 9 |
| Bradley Peek | 6 |
| Simon Studer | 5 |
| Khadija Abounaim | 5 |
| Daniel Faustin | 5 |
- Stock Market
- Insiders
- C. Tucker Barrie
- Company connections
